9/19/2013

Protea Biosciences will work with Virginia Commonwealth University's Center for Molecular Imaging to develop new molecular imaging approaches for evaluating Alzheimer's, cancer and other conditions. The partnership will allow Protea to combine its Laser Ablation Electrospray Ionization technology with VCU's capabilities for SPECT, PET and MRI/MRS imaging.

Related Summaries